Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Review: Beauty spot – put your best face forward
The Life

Review: Beauty spot – put your best face forward

We look at how your can give your skin a break. 

Helen van Berkel 02 Feb 2025
The scientific fight over whether ageing is a disease
Health

The scientific fight over whether ageing is a disease

The way we think about getting older is changing.

Fewer opening-day beds for Dunedin Hospital
Infrastructure

Fewer opening-day beds for Dunedin Hospital

The Government has confirmed the new $1.8b hospital will remain on the Cadbury site.

Oliver Lewis 31 Jan 2025
Govt confident $575,000 contract above board
Politics

Govt confident $575,000 contract above board

Govt rejects 'inference' of improper procurement of a $575,000 vaping contract.

Dileepa Fonseka 30 Jan 2025